GMO argues small cap quality is finally offering both long term appeal and near term valuation support. They note small cap valuations have fallen 39% from their post crisis peak, creating a setup that feels more like opportunity than hype. A key claim is that small cap quality historically delivered higher returns with lower volatility than the broad small cap universe.
Date published: October 2022
